CEP192 and cholangiocarcinoma: In addition, CEP192 was increased not only in HCC but also in other types of cancer, including cholangiocarcinoma, esophageal carcinoma, head and neck squamous cell carcinoma, and lung adenocarcinoma (Figure S1B).